Different mechanisms of negative efficacy. Distinguishing inverse agonists from negative antagonists

International Congress Series

Volumn 1249, Issue C, 2003, Pages 1-13

  Costa, Tommaso ^a   Ambrosio, Caterina ^a   Riitano, Daniela ^a   Molinari, Paola ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Drug efficacy; G protein coupled receptors; GDP binding; Inverse agonism; Negative antagonism

Indexed keywords

EID: 33845966240     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(03)00618-6     Document Type: Article

References (53)

1. Christopoulos, A., Kenakin, T., G protein-coupled receptor allosterism and complexing. Pharmacol. Rev. 54 (2002), 323–373.
2. Freissmuth, M., Waldhoer, M., Bofill-Cardona, E., Nanoff, C., G protein antagonists. Trends Pharmacol. Sci. 20 (1999), 237–245.
3. Wreggett, K., De Lean, A., The ternary complex model. Mol. Pharmacol. 26 (1984), 214–227.
4. Costa, T., Herz, A., Antagonists with negative intrinsic activity at δ opioid receptors coupled to GTP-binding proteins. Proc. Natl. Acad. Sci. U. S. A. 86 (1989), 7321–7325.
5. Braestrup, C., Nielsen, M., Honore, T., Benzodiazepine receptor ligands with positive and negative efficacy. Adv. Biochem. Psychopharmacol. 37 (1983), 237–245.
6. Nielsen, M., Braestrup, C., Ethyl beta-carboline-3-carboxylate shows differential benzodiazepine receptor interaction. Nature 286 (1980), 606–607.
7. A receptors. Trends Pharmacol. Sci. 18 (1997), 425–429.
8. Hilf, G., Jakobs, K.H., Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes. Eur. J. Pharmacol. 225:3 (1992), 245–252.
9. Gotze, K., Jakobs, K.H., Unoccupied beta-adrenoceptor-induced adenylyl cyclase stimulation in turkey erythrocyte membranes. Eur. J. Pharmacol. 268:2 (1994), 151–158.
10. Kjelsberg, M.A., Cotecchia, S., Ostrowski, J., Caron, M.G., Lefkowitz, R.J., Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J. Biol. Chem. 267:3 (1992), 1430–1433.
11. Samama, P., Cotecchia, S., Costa, T., Lefkowitz, R.J., A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 268:7 (1993), 4625–4636.
12. Shenker, A., Laue, L., Kosugi, S., Merendino, J.J. Jr., Minegishi, T., Cutler, G.B. Jr., A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365:6447 (1993), 652–654.
13. Parma, J., Duprez, L., Van Sande, J., Cochaux, P., Gervy, C., Mockel, J., Dumont, J., Vassart, G., Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:6447 (1993), 649–651.
14. Schutz, W., Freissmuth, M., Reverse intrinsic activity of antagonists on G protein-coupled receptors. Trends Pharmacol. Sci. 13:10 (1992), 376–380.
15. Milligan, G., Bond, R.A., Inverse agonism and the regulation of receptor number. Trends Pharmacol. Sci. 18 (1997), 468–474.
16. Leurs, R., Smit, M.J., Aleijwnse, A., Timmerman, H., Agonist independent regulation of constitutively active G protein coupled receptors. Trends Biochem. Sci. 23 (1998), 418–422.
17. de Ligt, R.A., Kourounakis, A.P., Ijzerman, A.P., Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery. Br. J. Pharmacol. 130:1 (2000), 1–12.
18. Strange, P.G., Mechanisms of inverse agonism at G-protein-coupled receptors. Trends Pharmacol. Sci. 23:2 (2002), 89–95.
19. Wyman, J., Allosteric linkage. J. Am. Chem. Soc. 89 (1967), 2202–2232.
20. Weber, G., Energetics of ligand binding to proteins. Adv. Protein Chem. 29 (1975), 1–83.
21. Colquhoun, D., Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br. J. Pharmacol. 125 (1998), 924–947.
22. Costa, T., Munson, P.J., Ogino, Y., Onaran, H.O., Rodbard, D., Drug efficacy at G protein-linked receptors: a thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol. 41 (1992), 549–560.
23. De Lean, A., Stadel, J.M., Lefkowitz, R.J., A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 255 (1980), 7108–7117.
24. Ehlert, F.J., The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium. Mol. Pharmacol. 28 (1985), 410–421.
25. Onaran, H.O., Costa, T., Rodbard D βγ-subunits of guanine nucleotide binding proteins and regulation of spontaneous receptor activity: thermodynamic model for the interaction between receptors and guanine nucleotide-binding protein subunits. Mol. Pharmacol. 43 (1993), 245–256.
26. Weiss, J.M., Morgan, P.H., Lutz, M.W., Kenakin, T.P., The cubic ternary complex receptor-occupancy model III. Resurrecting efficacy. J. Theor. Biol. 181 (1996), 381–397.
27. Leff, P., The two-state model of receptor activation. Trends Pharmacol. Sci. 16 (1995), 89–97.
28. Onaran, H.O., Costa, T., Agonist efficacy and allosteric models of receptor action. Ann. N.Y. Acad. Sci. 812 (1997), 98–115.
29. Kenakin, T., Efficacy at G-protein-coupled receptors. Nat. Rev. Drug Discov. 1 (2002), 103–110.
30. Kenakin, T., Drug efficacy at G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 42 (2002), 349–379.
31. Ferguson, K.M., Higashijima, T., Smigel, M.D., Gilman, A.G., The influence of bound GDP on the kinetics of guanine nucleotide binding to G proteins. J. Biol. Chem. 261:16 (1986), 7393–7399.
32. Higashijima, T., Ferguson, K.M., Smigel, M.D., Gilman, A.G., The effect of GTP and Mg2+ on the GTPase activity and the fluorescent properties of Go. J. Biol. Chem. 262:2 (1987), 757–761.
33. Higashijima, T., Ferguson, K.M., Sternweis, P.C., Ross, E.M., Smigel, M.D., Gilman, A.G., The effect of activating ligands on the intrinsic fluorescence of guanine nucleotide-binding regulatory proteins. J. Biol. Chem. 262:2 (1987), 752–756.
34. Higashijima, T., Ferguson, K.M., Sternweis, P.C., Smigel, M.D., Gilman, A.G., Effects of Mg2+ and the beta gamma-subunit complex on the interactions of guanine nucleotides with G proteins. J. Biol. Chem. 262:2 (1987), 762–766.
35. Cerione, R.A., Reconstitution of receptor/GTP-binding protein interactions. Biochim. Biophys. Acta 1071:4 (1991), 473–501.
36. Brandt, D.R., Ross, E.M., Catecholamine-stimulated GTPase cycle. Multiple sites of regulation by beta-adrenergic receptor and Mg2+ studied in reconstituted receptor-Gs vesicles. J. Biol. Chem. 261:4 (1986), 1656–1664.
37. Asano, T., Ross, E.M., Catecholamine-stimulated guanosine 5′-O-(3-thiotriphosphate) binding to the stimulatory GTP-binding protein of adenylate cyclase: kinetic analysis in reconstituted phospholipid vesicles. Biochemistry 23:23 (1984), 5467–5471.
38. Hartman, J.L., Northup, J.K., Functional reconstitution in situ of 5-hydroxytryptamine2c (5HT2c) receptors with alphaq and inverse agonism of 5HT2c receptor antagonists. J. Biol. Chem. 271:37 (1996), 22591–22597.
39. Glass, M., Northup, J.K., Agonist selective regulation of G proteins by cannabinoid CB1 and CB2 receptors. Mol. Pharmacol. 56 (1998), 1362–1369.
40. Tota, M.R., Schimerlik, M.I., Partial agonist effects on the interaction between the atrial muscarinic receptor and the inhibitory guanine nucleotide-binding protein in a reconstituted system. Mol. Pharmacol. 37:6 (1990), 996–1004.
41. Bouaboula, M., Perrachon, S., Milligan, L., Canatt, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J., Maffrand, J.P., Le Fur, G., Casellas, P., A selective inverse agonist for central canabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J. Biol. Chem. 272 (1997), 22330–22339.
42. Bourne, H.R., Sanders, D.A., McCormick, F., The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348 (1990), 125–132.
43. Higashijima, T., Uzu, S., Nakajima, T., Ross, E.M., Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J. Biol. Chem. 263 (1988), 6491–6494.
44. Higashijima, T., Ross, E.M., Mapping of the mastoparan-binding site on G proteins. Cross-linking of [125I-Tyr3, Cys11] mastoparan to Go. J. Biol. Chem. 266 (1991), 12655–12661.
45. Kisselev, O.G., Ermolaeva, M.V., Gautam, N., A farnesylated domain in the G protein gamma subunit is a specific determinant of receptor coupling. J. Biol. Chem. 269:34 (1994), 21399–21402.
46. Yasuda, H., Lindorfer, M.A., Woodfork, K.A., Fletcher, J.E., Garrison, J.C., Role of the prenyl group on the G protein subunit in coupling trimeric G proteins to A1 adenosine receptors. J. Biol. Chem. 271:31 (1996), 18588–18595.
47. Taylor, J.M., Jacob-Mosier, G.G., Lawton, R.G., VanDort, M., Neubig, R.R., Receptor and membrane interaction sites on Gbeta. A receptor-derived peptide binds to the carboxyl terminus. J. Biol. Chem. 271:7 (1996), 3336–3339.
48. Klein, S., Reuveni, H., Levitzki, A., Signal transduction by a nondissociable heterotrimeric yeast G protein. Proc. Natl. Acad. U. S. A. 97:7 (2000), 3219–3223.
49. Kisselev, O.G., Meyer, C.K., Heck, M., Ernst, O.P., Hofman, K.P., Signal transfer from rhodopsin to the G-protein: evidence for a two-site sequential fit mechanism. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 4898–4903.
50. Breivogel, C.S., Selley, D.E., Childers, S.R., Cannabinoid receptor agonist efficacy for stimulating [35S]GTPΓS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J. Biol. Chem. 273:27 (1998), 16865–16873.
51. Audinot, V., Newman-Tancredi, A., Millan, M.J., Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTPΓS versus [35S]-GTPΓS binding isotherms. Neuropharmacology 40 (2001), 57–64.
52. Waelbroeck, M., Activation of [35S]-GTPΓS binding through M1 muscarinic receptors in transfected CHO cell membranes. Mol. Pharmacol. 59:4 (2001), 875–885.
53. Milligan, G., Construction and analysis of function of G protein-coupled receptor-G protein fusion proteins. Methods Enzymol. 343 (2002), 260–273.